For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Fluocinolone acetonide - Uveitis
PAD Profile : Fluocinolone acetonide - Uveitis Important
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Dexamethasone
- Bevacizumab
- Infliximab
- Atropine sulfate
- Ciclosporin
- Methotrexate
- Azathioprine
- Mycophenolate mofetil
- Homatropine hydrobromide
Other Indications
Additional Documents
Committee Recommendations
The Area Prescribing Committee recommends fluocinolone acetonide as a treatment option in recurrent non-infectious uveitis in line with NICE TA590
Fluocinolone acetonide intravitreal implant will be considered RED on the traffic light system
Prescribing would be by hospital specialists only, in line with NICE TA596 using the Blueteq initiation and continuation forms.
Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.